Page 6 - Flipbook
P. 6

MAGNITUDE:



                            Study Review and Key Findings






                 A phase III randomized, placebo-controlled, double-blind study of niraparib plus
               abiraterone acetate and prednisone versus abiraterone acetate and prednisone in
                                        patients with metastatic prostate cancer











                            Kim Chi
   1   2   3   4   5   6   7   8   9   10   11